WO2001006953A1 - Intraluminal stent graft - Google Patents

Intraluminal stent graft Download PDF

Info

Publication number
WO2001006953A1
WO2001006953A1 PCT/US2000/020095 US0020095W WO0106953A1 WO 2001006953 A1 WO2001006953 A1 WO 2001006953A1 US 0020095 W US0020095 W US 0020095W WO 0106953 A1 WO0106953 A1 WO 0106953A1
Authority
WO
WIPO (PCT)
Prior art keywords
tube
diameter
stent
eptfe
conformable
Prior art date
Application number
PCT/US2000/020095
Other languages
French (fr)
Inventor
William M. Colone
Kevin G. Farl
Barbara L. Teeter
William L. Creer
Joseph B. Sinnott
Original Assignee
Endomed, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23421031&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO2001006953(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Endomed, Inc. filed Critical Endomed, Inc.
Priority to AT00952172T priority Critical patent/ATE286690T1/en
Priority to DK00952172T priority patent/DK1202682T3/en
Priority to DE60017411T priority patent/DE60017411T2/en
Priority to CA002378360A priority patent/CA2378360A1/en
Priority to AU64922/00A priority patent/AU6492200A/en
Priority to EP00952172A priority patent/EP1202682B1/en
Priority to JP2001511846A priority patent/JP2003505144A/en
Publication of WO2001006953A1 publication Critical patent/WO2001006953A1/en
Priority to US14/260,099 priority patent/US20140234948A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/89Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure the wire-like elements comprising two or more adjacent rings flexibly connected by separate members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • A61F2002/072Encapsulated stents, e.g. wire or whole stent embedded in lining
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • A61F2002/075Stent-grafts the stent being loosely attached to the graft material, e.g. by stitching
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0025Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • A61F2220/005Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements using adhesives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/006Additional features; Implant or prostheses properties not otherwise provided for modular
    • A61F2250/0063Nested prosthetic parts

Definitions

  • This invention relates to the field of intraluminal devices and particularly to lntraluminal grafts useful as an inner lining for blood vessels or other body conduits More particularly, the present invention provides tubular structures which can be expanded in a transversal direction to conform to the diameter of a particular vessel in a patient' s anatomy
  • vascular grafts have been used routinely for the repair of the human vasculature
  • These devices are typically flexible tubes of woven or knitted polyethylene terephthalate (PET or Dacron ®), porous polytetrafluoroethylene (PTFE) or porous polyurethane (PU)
  • Grafts of biological origin have also been used, typically comprising preserved human umbilical or bovine arteries
  • PET or Dacron ® polyethylene terephthalate
  • PTFE porous polytetrafluoroethylene
  • PU porous polyurethane
  • Grafts of biological origin typically comprising preserved human umbilical or bovine arteries
  • These conventional vascular grafts usually require invasive surgical procedures for insertion to expose at least the two ends of the segment of vessel to be repaired Frequently, it is necessary to expose the entire length of the vessel segment
  • grafts of various sizes are required to conform to the specific vasculature of a patient
  • Intraluminal vascular grafts can also be used to repair and provide structural support to aneurysmal vessels, particularly aortic arteries, by inserting an intraluminal vascular graft within the aneurysmal vessel so that it can withstand the blood pressure forces responsible for creating the aneurysm
  • intraluminal vascular grafts provide new blood contacting surfaces within the lumen of a diseased living vessel
  • intraluminal grafts are not limited to blood vessels, but have other applications, such as the repair and reconstruction of urinary tracts, biliary ducts, respiratory tracts and the like
  • an intraluminal graft is collapsed and inserted into a body conduit at a smaller diameter at a location remote from the intended repair site A catheter type of delivery system is then used to move the intraluminal graft into the repair site and then expand its diameter to conform to the inner surface of the living vessel Va ⁇ ous attachments, including adjustable stents or barbs, may also be used to secure the intraluminal
  • intraluminal vascular grafts with or without stents
  • an intraluminal vascular graft was suggested as early as 1912 in an article by Alexis Carrel ("Results of the permanent intubation of the thoracic aorta", Surg , Gyn and Ob 1912,15 245-248) Ersek (U S Patent 3,657,744) describes a method of using one or more stents to secure a flexible fabric vascular graft lntraluminally, the graft and stent having been introduced distally and delivered to the desired position with a separate delivery system According to this patent, the graft is introduced to the patient at its final diameter, since the device is placed following surgical exposure and resection of the injury site The stents are mechanically deployed by twisting an external apparatus
  • Choudhury desc ⁇ bes a similar method of repairing aortic aneurysms whereby a PET vascular graft is fitted at its ends with metal anchoring pms and pleated longitudinally to collapse the graft to a size small enough to allow for distal introduction
  • the barbed ancho ⁇ ng pins are deployed by advancing a wire to mechanically increase the diameter of the rings
  • Gianturco U S Patent 5,507,771
  • JP 080,7,771 describes a self-expanding stent assembly with an elastic covering for the prevention of restenosis
  • the entire device fully self expands upon deployment
  • Meyers U S Patent 5,700,285 desc ⁇ bes a seamed, thin walled intraluminal PTFE graft with balloon expandable stents
  • a balloon is employed to expand the graft and stents m location
  • Banas similarly desc ⁇ bes a reinforced vascular graft with radially expandable PTFE coupled with balloon expandable stents
  • the graft and stents are stretched beyond their plastic limits by a balloon to deploy the device
  • Fogarty U S Patent 5,824,037 describes modular tubular prostheses made of radially expandable cloth material and self-expanding stents
  • the graft mate ⁇ al is expanded by balloon, and the stents provide radial support for the reo ⁇ ented cloth fibers
  • an intraluminal device having a diameter which can be adjusted in vivo It is further desirable to provide a device that is self -expandable so that it can recover from external compression It is still further desirable to provide a device which can be deployed in a non-linear fashion, l e , first attaching the proximal end, then attaching the distal end, and, finally adjusting the diameter of the device between the two ends It is an objective of the present invention to provide an intraluminal device which has initially a small diameter so that it can be introduced easily into the vessel of a patient from a remote location and which can be easily expanded in place to any desired diameter thereby conforming to the diameter of the vessel being repaired or reinforced
  • a further objective is to provide an intraluminal device such as a stent graft including a conformable ePTFE tube and a self-expandable support stent
  • a further objective is to provide a novel process for making a conformable ePTFE tube usable as an intraluminal device which can be radially deformed easily up to a preset diameter without exceeding its plastic deformation limit
  • An intraluminal device constructed m accordance with this invention includes at least one self-expanding stent affixed to a tube formed of a porous, conformable ePTFE
  • the term 'conformable ePTFE tube' shall be used herein to define a tube made from ePTFE using a particular process described below
  • Porous ePTFE has a microstructure of nodes interconnected by fib ⁇ ls, as taught in U S Patents 3,953,566, 4,187,390 and 4,482,516
  • tubes of ePTFE have been made using a combined extrusion and longitudinal stretching process
  • a problem with these types of tubes is that because of the limitations of the machinery and processes used to produce them, their wall thickness become large once the tube diameters exceed 8mm and hence cannot be used for many prostheses requi ⁇ ng grafts of up to 25mm in diameter
  • standard ePTFE tubes cannot be expanded radially because they have a tendency to lose strength and split longitudinally when they are dilated
  • a further advantage of a conformable ePTFE tube is that its different longitudinal sections can be radially expanded independently of each other For example, the ends of a tube can be expanded first, followed by the middle section extending between the ends Moreover, these different sections need not be expanded to the same diameter
  • An intraluminal device produced in accordance with this invention comp ⁇ ses a conformable ePTFE tube which is preferably supported by a self-expandable stent
  • the intraluminal device or stent-graft itself is self-expandable both before and after it has been contracted
  • the term 'self-expanding stents' refers to stents which, when released, increase in diameter automatically without the need for an external expansion means, such as a balloon or other similar means
  • Devices of this type include stents of braided wire, such as those taught by Wallstent U S Patent 4,544,711, and stents of formed wire, such as those taught by Gianturco, U S Patent 4,580,568 These stents expand to a large diameter after being released from a constraining force which rest ⁇ cts them to a smaller diameter
  • Self-expanding stents may be formed from nitinol wire as taught by PCT US 92/03481 These
  • the conformable ePTFE tubes and self-expanding stents may be adjoined when both devices are in their compressed state Alternatively, a dilated PTFE tube and self expanding stents may be adjoined first and then the ePTFE tube and the stents are contracted to a compressed size together In either case, the production of said intraluminal devices is complete when the device is in its compressed state
  • the conformable ePTFE tubes may be affixed to either the exterior surface or the luminal surface of the self-expanding stent Alternatively, a first conformable ePTFE tube may be affixed to the exterior of the self-expanding stent and a second conformable ePTFE tube may be affixed to the luminal position of the self-expanding stent The first and second conformable ePTFE tubes may be affixed to each other in the spaces between or within the stents
  • the conformable ePTFE tubes may also be affixed to the self-expanding stent with an adhesive
  • the adhesive may be a thermoplastic fluoropolymer adhesive such as fluo ⁇ nated ethylene propylene (hereinafter FEP), perfluoroalkoxy (hereinafter PFA) polypropylene, or other similar material
  • FEP fluo ⁇ nated ethylene propylene
  • PFA perfluoroalkoxy
  • the stents may yet also be constrained between two tubes but be permanently affixed to neither
  • the two tubes are adhered to each other on their ends and in the spaces between and within the stents by thermal adhesion or fluoropolymer adhesive as described above
  • the luminal device thus formed may be delivered percutaneously, typically through the vasculature, in its compressed state.
  • the tube (or tubes) and stents are radially and irreversibly expanded by a balloon or other means. In so doing, the self-expanding stents expand toward their relaxed diameter. However, as the stents do not reach their relaxed diameter, they remain in radial tension, biasing the tube against the vessel wall.
  • Fig. 1 shows a flow chart for making a conformable ePTFE tube in accordance with this invention
  • Fig. 2 shows an isometric view of a stent being radially contracted and inserted into the tube produced by the method of Fig. 1 ;
  • Fig. 3 shows an alternate embodiment of the invention wherein a contracted tube and two stents are positioned over a second contracted tube;
  • Fig. 4 shows an elevational sectional view of embodiment of Fig. 3;
  • Fig. 5 shows an orthogonal view of the embodiment of Figs. 3 and 4;
  • Fig. 6 shows another embodiment of the invention wherein a self-expandable stent is affixed externally to a conformable ePTFE tube;
  • Fig. 7 shows an orthogonal view of a self-expandable stent affixed to a dilated tube, and the positioning of both over a small-diameter mandrel;
  • Fig. 8 shows an orthogonal view of a stent graft resulting from the operation of Fig. 7.
  • an intraluminal device comprising a conformable ePTFE tube is made in three stages illustrated in Fig 1.
  • the first stage consists of making an initial ePTFE tube.
  • This stage is well known in the prior art and is performed as follows: a.
  • a PTFE resin is compounded with a lubricant (preferably a petroleum distillate, such as naphtha); b.
  • the compound is compacted under pressure; c.
  • the compacted mass is extruded into a tube using a standard ram extrusion process to its predetermined diameter; d.
  • the tube is dried to remove the lubricant; e.
  • the dried tube is stretched longitudinally by up to 1000%; f.
  • the longitudinally stretched tube is sintered or cured at high temperature while its ends are fixed to insure that the tube does not shrink to its original length.
  • This stage is represented in Fig. 1 as step 10.
  • the resultant initial ePTFE tube has a relatively small diameter DI, of about 5-8mm or a relatively thick wall (greater than 0 010 inches)
  • DI the diameter of the initial ePTFE tube
  • this tube cannot be readily expanded or dilated because it has a tendency to lose strength or split longitudinally when subjected to radial forces
  • the next stage of the process is to dilate the initial ePTFE tube to a predetermined maximum diameter DM
  • This process of dilation involves progressively expanding the tube radially by a small, incremental amount at about 50° C using a mandrel (step 12) After each incremental dilation, the tube is then calendered on a flat surface (step 14) If the tube has not reached a desired diameter, l e DM, as determined in step 16 then in step 18, it is removed from the mandrel and inserted over a next mand
  • a third stage is implemented to contract or sh ⁇ nk the dilated tube radially as follows First, the dilated tube is removed from the mandrel having the diameter DM and inserted over a much smaller mandrel having a predetermined diameter DF (step 20)
  • This diameter DF should not be smaller than the diameter DI of the initial ePTFE tube, l e , at the end of step 10 in Fig 1
  • the diameter DF should be at least 4mm or more
  • the tube on this smaller mandrel is heated at about 200° C It was found that du ⁇ ng this heating operation, the tube contracts radially until it hugs the mandrel Typically this heating step may take about one to five minutes Following heating, the tube can be removed from the mandrel (step 24) Importantly, the inventors have found that the resulting conformable tube maintains its last nominal diameter DF However, if a radial force is applied internally to the tube by a balloon or other means, the conformable tube can be expanded to any diameter up to the maximum diameter DM established in step 16 without any physical damage
  • Figure 2 shows how to make an intraluminal device from a conformable tube and stents
  • a conformable PTFE tube 30 is prepared in accordance with the process described
  • Tube 30 includes a cylind ⁇ cal sidewall 32 and two open ends 34, 36
  • stents 40, 42 are provided
  • the process of inserting the stent 42 into tube 30 is illustrated, with stent 40 having been already inserted
  • Each of these stents is formed of a thin wire filament made for example of a nickel titanium alloy such as nitinol
  • the stents When relaxed, I e , when they are not radially compressed or otherwise restrained in any manner, the stents have a generally tubular shape with a diameter much larger than the diameter of the tube 30.
  • the stents 40, 42 may have a relaxed diameter of 28 mm while the tube 30 may have a diameter of about 3mm. Therefore, before or while the stents are inserted they must be compressed radially inwardly so that they can fit into the tube 30.
  • tube 42 is first shown in its uncompressed state 42'. It is then compressed radially inwardly until it has been reduced in diameter, and then finally pushed into the tube 30, as indicated by arrow B resulting in an intraluminal device.
  • an adhesive may be applied between the stents and the tube.
  • a suitable adhesive for this purpose may be FEP, PFA polypropylene or other similar materials.
  • the stents 40, 42 may be encapsulated between two tubes.
  • a mandrel 44 may be provided with a tube 46 made in the same manner as tube 30 but having a slightly smaller outer diameter. Tube 30 with stents 40, 42 is then pulled telescopically over the tube 46 as indicated by arrow C until the tubes 30, 46 are co-extensive, as shown in Fig. 4.
  • the two tubes 30 and 46 are then joined or bonded together.
  • One method of bonding the two tubes 30, 46 is to apply a bonding or adhesive agent between these tubes, such as FEP or PFA.
  • An alternative method is to sinter the two tubes together thereby allowing the walls of the tubes to adhere to each other.
  • wires 48, 49 may be wound around the ends of the tubes prior to sintering. After the sintering is complete, the wires 48 and 49 can be removed.
  • the resultant intraluminal device is shown in Fig. 5. Of course, the device of Fig.
  • a conformable ePTFE tube 50 is provided having an outer surface 52.
  • one or more stents 54 are mounted on and secured to the outer surface 52.
  • the stent 54 has a relaxed configuration in which it has a diameter much larger than the diameter of the tube 50.
  • the stent 54 can be installed by first positioning it over the tube 50, collapsing it radially inwardly until the stent 54 contacts the outer surface 52. The stent 54 can then be secured to the tube 50 by using an adhesive as described above.
  • an intraluminal device is produced as follows. First a dilated ePTFE tube 60 is provided by using steps 10-16 of the process of Fig. 1. Tube 60 may have a nominal diameter of about 25mm. Next, two self-expanding stents 62 and 64 similar to stents 40, 42 are inserted into the tube 60. On the left side of Fig.
  • stent 62 has already been inserted into the tube 60
  • the stents 62, 64 have a slightly larger diameter then tube 60, of for instance, 28 mm so that they apply a radial tensioning force on tube 60
  • the tube 60 with stents 62, 64 is positioned on a small diameter mandrel 66
  • mandrel 66 has a diameter of about 4-6mm
  • the tube 60, the mandrel 66 and the stents 62 and 64 are placed into an oven heated to about 200°C
  • the mandrel 66 and the other components are kept in the oven until the tube 60 shrinks down to the size of mandrel 66 In this contracting process, as the mandrel shrinks, it automatically collapses the stents 62, 64 as well
  • the mandrel 66 is withdrawn leaving the intraluminal device 68, shown in Fig 8
  • the intraluminal devices of Figs 5 and 6 may also be produced by assembling the ePTFE tube(s) and stent(s) together before the ePTFE tubes are contracted
  • suitable means such an adhesive, may have to be provided to insure that the stents and tubes do not disassociate during the contraction
  • an intraluminal device is formed in accordance with this invention by first producing a novel conformable ePTFE tube and then assembling this tube with one or more self-expandable stents in such a manner that the composite graft has a smaller diameter than the relaxed diameter of the stents
  • the stents can be either inside the conformable ePTFE tube outside the conformable ePTFE tube or can be disposed or captured between two conformable ePTFE tubes
  • the conformable ePTFE tubes have a maximum dilation diameter to which it can be safely expanded, which maximum diameter is smaller than the relaxed diameter of the stents
  • the intraluminal device formed is packaged for storage and shipping
  • the intraluminal device is used as follows First, the device is delivered percutaneously to a body vessel that needs to be repaired, using a suitable catheter Next, a standard balloon such as an embolectomy or angioplasty balloon is inserted into the device and the balloon is inflated slowly until the device has the same diameter as the vessel, at which point the balloon is deflated and removed Other known mechanical means of expanding the device may be used as well
  • the intraluminal device must be chosen so that the maximum dilation diameter of the tube is equal to, or larger than the vessel diameter
  • the stents affixed to the tube are expanded as well Since the stents are self expanding, they maintain their tubular shape and do not collapse after the balloon is deflated and removed Moreover, since the diameter of the device is always smaller than the relaxed diameter of the stents, the stents are always radially tensioned, thereby biasing the conformable ePTFE tube radially outwardly Of course, this radial force from the stents on the tube is much smaller than the force required to expand the tube further Therefore the stents provide support for the tube and keep it open while the vessel resumes its normal function
  • the actual process for expanding the device depends on its diameter and length If the device is short, it may be expanded in a single operation If it is a long device, then it can be expanded in three or more stages During the first two stages, the ends of the device are expanded to engage the vessel and anchor the device to the vessel Then the center portion of the device is expanded.
  • This process is described in detail in commonly assigned co-pending application S N 08/885,625 filed February 29, 1998 entitled MULTIPLE DIAMETER EXPANDABLE GRAFT FOR BLOOD VESSEL AND METHOD OF DEPLOYING THE SAME, now U S Patent No

Abstract

An intraluminal device such as a stent graft is formed of a conformable ePTFE tube and preferably a compressed self-expanding stent affixed to the tube. The conformable tube is made by a special process which insures that the tube is radially deformable up to a predetermined diameter without exceeding the plastic deformation limit of the tube. The stent has a relaxed diameter larger than the diameter of the expanded tube after insertion so that the tube is biased to a cylindrical shape. The process for making the tube involves progressively dilating a small diameter extruded tube until a desired diameter is achieved. The tube is then contracted on a small diameter mandrel by heating.

Description

INTRALUMINAL STENT GRAFT
BACKGROUND OF THE INVENTION
A Field of Invention
This invention relates to the field of intraluminal devices and particularly to lntraluminal grafts useful as an inner lining for blood vessels or other body conduits More particularly, the present invention provides tubular structures which can be expanded in a transversal direction to conform to the diameter of a particular vessel in a patient' s anatomy
B Description of the Prior Art
Conventional vascular grafts have been used routinely for the repair of the human vasculature These devices are typically flexible tubes of woven or knitted polyethylene terephthalate (PET or Dacron ®), porous polytetrafluoroethylene (PTFE) or porous polyurethane (PU) Grafts of biological origin have also been used, typically comprising preserved human umbilical or bovine arteries These conventional vascular grafts usually require invasive surgical procedures for insertion to expose at least the two ends of the segment of vessel to be repaired Frequently, it is necessary to expose the entire length of the vessel segment These types of procedures can cause major trauma to the patient with corresponding lengthy recovery periods, and may result in occasional mortality In addition, grafts of various sizes are required to conform to the specific vasculature of a patient
Other methods have evolved which use intraluminal vascular grafts, adjustable stents providing structural support, or a combination of both These devices are preferably remotely introduced into a body cavity using a catheter type of delivery system Alternatively, these devices may be directly implanted by invasive surgery The intent of these methods is to maintain patency after an occluded vessel has been reopened using balloon angioplasty, laser angioplasty, atherectomy, roto-ablation, invasive surgery, or a combination of these treatments
Intraluminal vascular grafts can also be used to repair and provide structural support to aneurysmal vessels, particularly aortic arteries, by inserting an intraluminal vascular graft within the aneurysmal vessel so that it can withstand the blood pressure forces responsible for creating the aneurysm In this environment, intraluminal vascular grafts provide new blood contacting surfaces within the lumen of a diseased living vessel Moreover, intraluminal grafts are not limited to blood vessels, but have other applications, such as the repair and reconstruction of urinary tracts, biliary ducts, respiratory tracts and the like In the prior art, an intraluminal graft is collapsed and inserted into a body conduit at a smaller diameter at a location remote from the intended repair site A catheter type of delivery system is then used to move the intraluminal graft into the repair site and then expand its diameter to conform to the inner surface of the living vessel Vaπous attachments, including adjustable stents or barbs, may also be used to secure the intraluminal graft to the subject vessel at the desired location without the necessity of invasive surgery
Various attempts have been made to provide intraluminal vascular grafts with or without stents For example, an intraluminal vascular graft was suggested as early as 1912 in an article by Alexis Carrel ("Results of the permanent intubation of the thoracic aorta", Surg , Gyn and Ob 1912,15 245-248) Ersek (U S Patent 3,657,744) describes a method of using one or more stents to secure a flexible fabric vascular graft lntraluminally, the graft and stent having been introduced distally and delivered to the desired position with a separate delivery system According to this patent, the graft is introduced to the patient at its final diameter, since the device is placed following surgical exposure and resection of the injury site The stents are mechanically deployed by twisting an external apparatus
Choudhury (U S Patent 4,140,126) descπbes a similar method of repairing aortic aneurysms whereby a PET vascular graft is fitted at its ends with metal anchoring pms and pleated longitudinally to collapse the graft to a size small enough to allow for distal introduction The barbed anchoπng pins are deployed by advancing a wire to mechanically increase the diameter of the rings
Rhodes (U S Patent 5,122,154), descπbes endovascular bypass grafts for intraluminal use which comprises a sleeve made of standard graft mateπal and unidirectionally hinged stents The graft is longitudinally pleated for introduction, and the stents are expanded in location by external means Lee (U S Patent 5,123,917) describes an intraluminal vascular graft made of flexible, radially expandable mateπal and balloon-expandable stents The mateπal and stents are both radially expanded in situ using, e g , a balloon
Gianturco (U S Patent 5,507,771), describes a self-expanding stent assembly with an elastic covering for the prevention of restenosis The entire device fully self expands upon deployment Meyers (U S Patent 5,700,285) descπbes a seamed, thin walled intraluminal PTFE graft with balloon expandable stents A balloon is employed to expand the graft and stents m location
Banas (U S Patent 5,749,880) similarly descπbes a reinforced vascular graft with radially expandable PTFE coupled with balloon expandable stents The graft and stents are stretched beyond their plastic limits by a balloon to deploy the device Fogarty (U S Patent 5,824,037) describes modular tubular prostheses made of radially expandable cloth material and self-expanding stents The graft mateπal is expanded by balloon, and the stents provide radial support for the reoπented cloth fibers
Martin (European Patent Application EP 0893108 A2,) describes a stent-graft with a πbbon affixing a portion of a stent to a PTFE graft All of these devices have a number of drawbacks that make them undesirable for clinical use
First, devices made of non-expandable mateπals and having predetermined deployed diameters cannot accommodate variations in patient physiology, and changes in diameter between the distal and proximal implantation site
Second, devices with plastically deformable stents cannot withstand external compression without deformation of the stents, limiting the use of the devices m patient's extremities
Third, fully self-expanding devices must be deployed through a sheath, which typically compels the user to deploy the devices linearly, l e from the proximal to the distal end
OBJECTIONS AND SUMMARY OF THE INVENTION Therefore, it would be advantageous to provide an intraluminal device having a diameter which can be adjusted in vivo It is further desirable to provide a device that is self -expandable so that it can recover from external compression It is still further desirable to provide a device which can be deployed in a non-linear fashion, l e , first attaching the proximal end, then attaching the distal end, and, finally adjusting the diameter of the device between the two ends It is an objective of the present invention to provide an intraluminal device which has initially a small diameter so that it can be introduced easily into the vessel of a patient from a remote location and which can be easily expanded in place to any desired diameter thereby conforming to the diameter of the vessel being repaired or reinforced
A further objective is to provide an intraluminal device such as a stent graft including a conformable ePTFE tube and a self-expandable support stent
A further objective is to provide a novel process for making a conformable ePTFE tube usable as an intraluminal device which can be radially deformed easily up to a preset diameter without exceeding its plastic deformation limit
Other objectives and advantages of the invention shall become apparent from the following description of the invention
An intraluminal device constructed m accordance with this invention includes at least one self-expanding stent affixed to a tube formed of a porous, conformable ePTFE The term 'conformable ePTFE tube' shall be used herein to define a tube made from ePTFE using a particular process described below Porous ePTFE has a microstructure of nodes interconnected by fibπls, as taught in U S Patents 3,953,566, 4,187,390 and 4,482,516 Typically, tubes of ePTFE have been made using a combined extrusion and longitudinal stretching process A problem with these types of tubes is that because of the limitations of the machinery and processes used to produce them, their wall thickness become large once the tube diameters exceed 8mm and hence cannot be used for many prostheses requiπng grafts of up to 25mm in diameter Moreover, standard ePTFE tubes cannot be expanded radially because they have a tendency to lose strength and split longitudinally when they are dilated
A method of producing dilated ePTFE tubes with much larger diameters (up to 25mm and more) with extremely thin walls (down to 0 008 inches and less) by progressive dilation of an initial ePTFE tube by an incremental amount followed by, calendering at a preselected temperature is taught by co-pending commonly assigned U S Patent Application 09/244,343 by Colone et al entitled "METHOD OF MAKING LARGE DIAMETER VASCULAR PROSTHESES AND A VASCULAR PROSTHESIS MADE BY SAID METHOD" filed February 4, 1999, now and incorporated herein by reference In the present invention, an ePTFE tube which has been dilated by the process descπbed above, is shrunk radially by inserting a small diameter mandrel into the dilated tube and sintering the tube at a predetermined temperature The present inventors have found that by sinteπng the dilated ePTFE tube over a small mandrel causes the dilated ePTFE tube to shπnk radially around the mandrel thereby producing a tube which is homogeneous and has an inner diameter determined by the diameter of the mandrel The only limitation on this process is that the mandrel cannot have a smaller diameter than the inner diameter of the initial ePTFE (I e , the tube made by extrusion) Importantly, the tube contracted in this manner can be readily expandable by applying radial forces to it In fact the tube can be expanded radially up to its ongmal dilated size without causing it to lose strength or split In other words, the plastic deformation limit of this tube is essentially the diameter of the dilated tube The tube produced by this process is called herein a conformable ePTFE tube to differentiate it from other ePTFE tubes suggested by the pπor art
A further advantage of a conformable ePTFE tube is that its different longitudinal sections can be radially expanded independently of each other For example, the ends of a tube can be expanded first, followed by the middle section extending between the ends Moreover, these different sections need not be expanded to the same diameter
An intraluminal device produced in accordance with this invention compπses a conformable ePTFE tube which is preferably supported by a self-expandable stent In this manner, the intraluminal device or stent-graft itself is self-expandable both before and after it has been contracted The term 'self-expanding stents' refers to stents which, when released, increase in diameter automatically without the need for an external expansion means, such as a balloon or other similar means Devices of this type include stents of braided wire, such as those taught by Wallstent U S Patent 4,544,711, and stents of formed wire, such as those taught by Gianturco, U S Patent 4,580,568 These stents expand to a large diameter after being released from a constraining force which restπcts them to a smaller diameter Self-expanding stents may be formed from nitinol wire as taught by PCT US 92/03481 These stents expand in diameter when exposed to a slight increase in temperature The self-expanding stents employed in this invention are selected such that the radial force created when these stents are in their compressed state and inserted into a conformable ePTFE tube is less than the force needed to radially expand the conformable ePTFE tubes The stents are further selected such that their maximum intended deployment diameter is less than their relaxed diameter, so that when deployed as intended (I e attached to a graft), they provide radial tension to the graft In this manner, once the stents are affixed to a conformable ePTFE (as descπbed more fully below), the tube is biased toward a cylmdπcal shape by the stent both before and after expansion
The conformable ePTFE tubes and self-expanding stents may be adjoined when both devices are in their compressed state Alternatively, a dilated PTFE tube and self expanding stents may be adjoined first and then the ePTFE tube and the stents are contracted to a compressed size together In either case, the production of said intraluminal devices is complete when the device is in its compressed state
The conformable ePTFE tubes may be affixed to either the exterior surface or the luminal surface of the self-expanding stent Alternatively, a first conformable ePTFE tube may be affixed to the exterior of the self-expanding stent and a second conformable ePTFE tube may be affixed to the luminal position of the self-expanding stent The first and second conformable ePTFE tubes may be affixed to each other in the spaces between or within the stents
The conformable ePTFE tubes may also be affixed to the self-expanding stent with an adhesive The adhesive may be a thermoplastic fluoropolymer adhesive such as fluoπnated ethylene propylene (hereinafter FEP), perfluoroalkoxy (hereinafter PFA) polypropylene, or other similar material The first and second PTFE tubes may then be affixed to each other by heating them above the crystalline melting point of the PTFE tubes adequately to cause the two coveπngs to thermally adhere, or alternatively they may be affixed by an adhesive such as FEP
The stents may yet also be constrained between two tubes but be permanently affixed to neither The two tubes are adhered to each other on their ends and in the spaces between and within the stents by thermal adhesion or fluoropolymer adhesive as described above The luminal device thus formed may be delivered percutaneously, typically through the vasculature, in its compressed state. Once reaching the intended delivery site, the tube (or tubes) and stents are radially and irreversibly expanded by a balloon or other means. In so doing, the self-expanding stents expand toward their relaxed diameter. However, as the stents do not reach their relaxed diameter, they remain in radial tension, biasing the tube against the vessel wall.
BRIEF DESCRIPTION OF THE DRAWINGS
Fig. 1 shows a flow chart for making a conformable ePTFE tube in accordance with this invention;
Fig. 2 shows an isometric view of a stent being radially contracted and inserted into the tube produced by the method of Fig. 1 ;
Fig. 3 shows an alternate embodiment of the invention wherein a contracted tube and two stents are positioned over a second contracted tube;
Fig. 4 shows an elevational sectional view of embodiment of Fig. 3;
Fig. 5 shows an orthogonal view of the embodiment of Figs. 3 and 4; Fig. 6 shows another embodiment of the invention wherein a self-expandable stent is affixed externally to a conformable ePTFE tube;
Fig. 7 shows an orthogonal view of a self-expandable stent affixed to a dilated tube, and the positioning of both over a small-diameter mandrel; and
Fig. 8 shows an orthogonal view of a stent graft resulting from the operation of Fig. 7.
DESCRIPTION OF THE PREFERRED EMBODIMENTS
In accordance with this invention, an intraluminal device comprising a conformable ePTFE tube is made in three stages illustrated in Fig 1. The first stage consists of making an initial ePTFE tube. This stage is well known in the prior art and is performed as follows: a. A PTFE resin is compounded with a lubricant (preferably a petroleum distillate, such as naphtha); b. The compound is compacted under pressure; c. The compacted mass is extruded into a tube using a standard ram extrusion process to its predetermined diameter; d. The tube is dried to remove the lubricant; e. The dried tube is stretched longitudinally by up to 1000%; f. The longitudinally stretched tube is sintered or cured at high temperature while its ends are fixed to insure that the tube does not shrink to its original length.
This stage is represented in Fig. 1 as step 10. As explained previously, because of various limitations associated with the extrusion process (including, for example the maximum extrusion force that can be generated by existing ram extruders) the resultant initial ePTFE tube has a relatively small diameter DI, of about 5-8mm or a relatively thick wall (greater than 0 010 inches) Moreover, this tube cannot be readily expanded or dilated because it has a tendency to lose strength or split longitudinally when subjected to radial forces The next stage of the process is to dilate the initial ePTFE tube to a predetermined maximum diameter DM This process of dilation involves progressively expanding the tube radially by a small, incremental amount at about 50° C using a mandrel (step 12) After each incremental dilation, the tube is then calendered on a flat surface (step 14) If the tube has not reached a desired diameter, l e DM, as determined in step 16 then in step 18, it is removed from the mandrel and inserted over a next mandrel having an incrementally larger diameter The steps 12-18 are repeated several times until a tube of a desired diameter DM is reached
The resulting tube ePTFE can be made to very precise dimensions and is dimensionally stable Importantly, tubes of diameters of 25mm or more can be made using this process Details of the procedure descπbed so far are found in co-pending application to Colone et al identified above
However, in the present invention, a third stage is implemented to contract or shπnk the dilated tube radially as follows First, the dilated tube is removed from the mandrel having the diameter DM and inserted over a much smaller mandrel having a predetermined diameter DF (step 20) This diameter DF should not be smaller than the diameter DI of the initial ePTFE tube, l e , at the end of step 10 in Fig 1 For example, if after extrusion the initial ePTFE tube has a diameter of 4mm, the diameter DF should be at least 4mm or more
Next, the tube on this smaller mandrel is heated at about 200° C It was found that duπng this heating operation, the tube contracts radially until it hugs the mandrel Typically this heating step may take about one to five minutes Following heating, the tube can be removed from the mandrel (step 24) Importantly, the inventors have found that the resulting conformable tube maintains its last nominal diameter DF However, if a radial force is applied internally to the tube by a balloon or other means, the conformable tube can be expanded to any diameter up to the maximum diameter DM established in step 16 without any physical damage
Figure 2 shows how to make an intraluminal device from a conformable tube and stents First, a conformable PTFE tube 30 is prepared in accordance with the process described Tube 30 includes a cylindπcal sidewall 32 and two open ends 34, 36 Once tube 30 is completed, one or more stents are affixed to the tube 30 For example, in Fig 2 stents 40, 42 are provided The process of inserting the stent 42 into tube 30 is illustrated, with stent 40 having been already inserted Each of these stents is formed of a thin wire filament made for example of a nickel titanium alloy such as nitinol When relaxed, I e , when they are not radially compressed or otherwise restrained in any manner, the stents have a generally tubular shape with a diameter much larger than the diameter of the tube 30. For example, for an endovascular stent placement procedure, the stents 40, 42 may have a relaxed diameter of 28 mm while the tube 30 may have a diameter of about 3mm. Therefore, before or while the stents are inserted they must be compressed radially inwardly so that they can fit into the tube 30. In Fig. 2, tube 42 is first shown in its uncompressed state 42'. It is then compressed radially inwardly until it has been reduced in diameter, and then finally pushed into the tube 30, as indicated by arrow B resulting in an intraluminal device.
In order to insure that the stents 40 and 42 do not separate from the tube 30, an adhesive may be applied between the stents and the tube. A suitable adhesive for this purpose may be FEP, PFA polypropylene or other similar materials.
Alternatively, the stents 40, 42 may be encapsulated between two tubes. For example, as shown in Fig. 3, a mandrel 44 may be provided with a tube 46 made in the same manner as tube 30 but having a slightly smaller outer diameter. Tube 30 with stents 40, 42 is then pulled telescopically over the tube 46 as indicated by arrow C until the tubes 30, 46 are co-extensive, as shown in Fig. 4.
The two tubes 30 and 46 are then joined or bonded together. One method of bonding the two tubes 30, 46 is to apply a bonding or adhesive agent between these tubes, such as FEP or PFA. An alternative method is to sinter the two tubes together thereby allowing the walls of the tubes to adhere to each other. During sintering, in order to eliminate any potential creep, wires 48, 49 may be wound around the ends of the tubes prior to sintering. After the sintering is complete, the wires 48 and 49 can be removed. The resultant intraluminal device is shown in Fig. 5. Of course, the device of Fig. 5 may also be made by first positioning the stents 40, 42 over tube 46, pulling the tube 30 over the stents 40, 42 and tube 46 and then bonding the tubes 30, 46 together. In another alternate embodiment, shown in Fig. 6, a conformable ePTFE tube 50 is provided having an outer surface 52. In this embodiment one or more stents 54 are mounted on and secured to the outer surface 52. As in the embodiments of Figs. 2-5, the stent 54 has a relaxed configuration in which it has a diameter much larger than the diameter of the tube 50. The stent 54 can be installed by first positioning it over the tube 50, collapsing it radially inwardly until the stent 54 contacts the outer surface 52. The stent 54 can then be secured to the tube 50 by using an adhesive as described above.
In yet another embodiment, referring to Fig. 7, an intraluminal device is produced as follows. First a dilated ePTFE tube 60 is provided by using steps 10-16 of the process of Fig. 1. Tube 60 may have a nominal diameter of about 25mm. Next, two self-expanding stents 62 and 64 similar to stents 40, 42 are inserted into the tube 60. On the left side of Fig. 7, stent 62 has already been inserted into the tube 60 Preferably the stents 62, 64 have a slightly larger diameter then tube 60, of for instance, 28 mm so that they apply a radial tensioning force on tube 60 Next, the tube 60 with stents 62, 64 is positioned on a small diameter mandrel 66 If the tube 60 was obtained from an initial ePTFE tube of 4mm m steps 10-16 then mandrel 66 has a diameter of about 4-6mm Next, the tube 60, the mandrel 66 and the stents 62 and 64 are placed into an oven heated to about 200°C The mandrel 66 and the other components are kept in the oven until the tube 60 shrinks down to the size of mandrel 66 In this contracting process, as the mandrel shrinks, it automatically collapses the stents 62, 64 as well When the contracting process is complete, the mandrel 66 is withdrawn leaving the intraluminal device 68, shown in Fig 8 The device 68 in Fig 8 is essentially identical in structure to the device 43 in Fig 2, the only difference being the manner in which the two stent grafts are produced
The intraluminal devices of Figs 5 and 6 may also be produced by assembling the ePTFE tube(s) and stent(s) together before the ePTFE tubes are contracted In each of these embodiment suitable means, such an adhesive, may have to be provided to insure that the stents and tubes do not disassociate during the contraction
To summarize, an intraluminal device is formed in accordance with this invention by first producing a novel conformable ePTFE tube and then assembling this tube with one or more self-expandable stents in such a manner that the composite graft has a smaller diameter than the relaxed diameter of the stents The stents can be either inside the conformable ePTFE tube outside the conformable ePTFE tube or can be disposed or captured between two conformable ePTFE tubes Importantly, the conformable ePTFE tubes have a maximum dilation diameter to which it can be safely expanded, which maximum diameter is smaller than the relaxed diameter of the stents The intraluminal device formed is packaged for storage and shipping
The intraluminal device is used as follows First, the device is delivered percutaneously to a body vessel that needs to be repaired, using a suitable catheter Next, a standard balloon such as an embolectomy or angioplasty balloon is inserted into the device and the balloon is inflated slowly until the device has the same diameter as the vessel, at which point the balloon is deflated and removed Other known mechanical means of expanding the device may be used as well
The intraluminal device must be chosen so that the maximum dilation diameter of the tube is equal to, or larger than the vessel diameter As the device is expanded radially by the balloon, the stents affixed to the tube are expanded as well Since the stents are self expanding, they maintain their tubular shape and do not collapse after the balloon is deflated and removed Moreover, since the diameter of the device is always smaller than the relaxed diameter of the stents, the stents are always radially tensioned, thereby biasing the conformable ePTFE tube radially outwardly Of course, this radial force from the stents on the tube is much smaller than the force required to expand the tube further Therefore the stents provide support for the tube and keep it open while the vessel resumes its normal function
The actual process for expanding the device depends on its diameter and length If the device is short, it may be expanded in a single operation If it is a long device, then it can be expanded in three or more stages During the first two stages, the ends of the device are expanded to engage the vessel and anchor the device to the vessel Then the center portion of the device is expanded This process is described in detail in commonly assigned co-pending application S N 08/885,625 filed February 29, 1998 entitled MULTIPLE DIAMETER EXPANDABLE GRAFT FOR BLOOD VESSEL AND METHOD OF DEPLOYING THE SAME, now U S Patent No
Obviously numerous modifications may be made to this invention without departing from its scope as defined in the appended claims
While the invention has been illustrated and described in detail in the drawings and foregoing description, the same is to be considered as illustrative and not restπctive in character, it being understood that only the prefeπed embodiment has been shown and described, and that all changes and modifications that come within the spirit of the invention are desired to be protected

Claims

We claim
1 An intraluminal device for insertion into a patient's vessel, said device comprising a conformable tube having a predetermined diameter and length and capable of being radially expanded up to a diameter of said vessel
2 The device of claim 1 wherein said tube is made of ePTFE
3 The device of claim 1 further comprising a self-expandable stent affixed to said conformable tube
4 The device of claim 3 wherein said self-expandable stent has a relaxed diameter formed when said self-expandable stent is not associated with said tube said relaxed diameter being larger than said predetermined diameter
5 An intraluminal device for insertion into a patient's vessel and comprising a conformable ePTFE tube adapted to be radially expandable when an expansion force is applied, and a compressed self-expandable stent affixed to said tube, said stent generating a radial force on said tube which is smaller than said expansion force
6 The device of claim 5 wherein said stent is disposed inside said tube
7 The device of claim 5 wherein said stent is disposed outside said tube
8 An intraluminal device comprising an outer conformable ePTFE tube expandable in response to an expansion force, an inner conformable ePTFE tube, positioned concentrically within the outer tube, a self-expanding stent confined between the inner and outer tubes wherein the inner and outer tubes are adhered to each other
9 The device of claim 8 wherein said stent is compressed and the radial force of the compressed stent is below said expansion force
10 A method of producing an intraluminal device comprising providing a conformable ePTFE tube capable of being expanded to a predetermined diameter without exceeding its plastic deformation limit, providing a self-expanding stent, and affixing said stent to said tube, wherein the radial force required to expand said tube is greater than the radial force of the compressed stent member
1 1 The method of claim 10 wherein said conformable ePTFE tube is formed by providing a dilated ePTFE tube and compressing said tube to a small diameter
12 The method of claim 11 wherein said dilated ePTFE tube has a dilated diameter and where said predetermined diameter coπesponds to said dilated diameter
13 The method of claim 12 wherein said stent has a relaxed diameter defined when said stent is not compressed, said relaxed diameter being larger than said predetermined diameter, whereby after said radial expansion, said tube is biased into a cylindπcal shape by said stent
14 The method of claim 11 wherein said stent is affixed to said tube after the contraction of
15 The method of claim 10 wherein said stent is affixed after inserting said stent into said tube
16 The method of claim 10 wherein said stent is affixed to an outer surface of said tube
17 The method of claim 10 wherein said stent is adhesively affixed to said tube
18 A method of producing an intraluminal device comprising providing an outer conformable ePTFE tube, positioning at least one, self-expanding stent within said outer tube, providing an inner radially conformable ePTFE tube, positioning said inner tube concentπcally inside said outer tube and said compressed stent, and adheπng said inner and outer tubes to each other
19 The method of claim 18 wherein said steps of providing said conformable ePTFE tubes includes providing corresponding dilated ePTFE tubes and contracting said dilated tubes to form said conformable ePTFE tubes
20 The method of claim 19 wherein said stent is inserted into said outer tube after said outer tube is contracted
21 The method of claim 19 wherein said stent is inserted into said outer tube before said outer tube is contracted
22 The method of claim 18 wherein said step of adheπng includes heating said tubes
23 The method of claim 18 wherein said step of adheπng includes providing an adhesive
24 A method of producing a conformable ePTFE tube adapted for use as an intraluminal device by inserting said tube into a patient's vessel and expanding said conformable ePTFE tube radially to a predetermined diameter to conform to a diameter of said vessel, said method comprising the steps of providing an initial ePTFE tube of a first diameter, dilating said initial tube radially to form a dilated tube having a second diameter, and contracting said dilated tube to form said conformable tube having a third diameter, said conformable tube being radially expandable up to said second diameter without exceeding the plastic expansion limit of said final tube
25 The method of claim 24 wherein said initial tube is formed by extruding ePTFE mateπal into an extruded tube, and stretching said extruded tube longitudinally
26 The method of claim 24 wherein said dilated tube is produced by expanding said initial tube incrementally, and calendering said tube between each expansion until said second diameter is reached
27 The method of claim 24 wherein said dilated tube is contracted by inserting a mandrel into said dilated tube and sintering said dilated tube at a predetermined temperature
28 The method of claim 27 wherein said mandrel has a mandrel diameter equal to said third diameter
29 The method of claim 24 wherein said first diameter is in the range l-10mm, said second diameter is in the range of 4-30mm and said third diameter is larger than 4mm
PCT/US2000/020095 1999-07-26 2000-07-24 Intraluminal stent graft WO2001006953A1 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
AT00952172T ATE286690T1 (en) 1999-07-26 2000-07-24 INTRALUMINAL STENT TISSUES
DK00952172T DK1202682T3 (en) 1999-07-26 2000-07-24 Intraluminal transplant stent
DE60017411T DE60017411T2 (en) 1999-07-26 2000-07-24 INTRALUMINAL STENT FABRICS
CA002378360A CA2378360A1 (en) 1999-07-26 2000-07-24 Intraluminal stent graft
AU64922/00A AU6492200A (en) 1999-07-26 2000-07-24 Intraluminal stent graft
EP00952172A EP1202682B1 (en) 1999-07-26 2000-07-24 Intraluminal stent graft
JP2001511846A JP2003505144A (en) 1999-07-26 2000-07-24 Endoluminal stent-graft
US14/260,099 US20140234948A1 (en) 1999-08-03 2014-04-23 Molecular motor

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/361,192 1999-07-26
US09/361,192 US6402779B1 (en) 1999-07-26 1999-07-26 Balloon-assisted intraluminal stent graft

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US10/061,377 Continuation-In-Part US7349834B2 (en) 1999-08-03 2002-02-01 Molecular motor

Publications (1)

Publication Number Publication Date
WO2001006953A1 true WO2001006953A1 (en) 2001-02-01

Family

ID=23421031

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/020095 WO2001006953A1 (en) 1999-07-26 2000-07-24 Intraluminal stent graft

Country Status (10)

Country Link
US (1) US6402779B1 (en)
EP (2) EP1202682B1 (en)
JP (1) JP2003505144A (en)
AT (1) ATE286690T1 (en)
AU (1) AU6492200A (en)
CA (1) CA2378360A1 (en)
DE (1) DE60017411T2 (en)
ES (1) ES2235925T3 (en)
PT (1) PT1202682E (en)
WO (1) WO2001006953A1 (en)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1719538A1 (en) * 2004-02-27 2006-11-08 Sumitomo Electric Industries, Ltd. Composite structure and process for producing the same
US7226558B2 (en) 2000-11-22 2007-06-05 Bard Peripheral Vascular, Inc. Method of making an expanded polytetrafluoroethylene structure
JP2009291626A (en) * 2001-12-20 2009-12-17 Trivascular2 Inc Method and apparatus for manufacturing endovascular graft section
US8252036B2 (en) 2006-07-31 2012-08-28 Syntheon Cardiology, Llc Sealable endovascular implants and methods for their use
US9408607B2 (en) 2009-07-02 2016-08-09 Edwards Lifesciences Cardiaq Llc Surgical implant devices and methods for their manufacture and use
US9566178B2 (en) 2010-06-24 2017-02-14 Edwards Lifesciences Cardiaq Llc Actively controllable stent, stent graft, heart valve and method of controlling same
US9585743B2 (en) 2006-07-31 2017-03-07 Edwards Lifesciences Cardiaq Llc Surgical implant devices and methods for their manufacture and use
US9814611B2 (en) 2007-07-31 2017-11-14 Edwards Lifesciences Cardiaq Llc Actively controllable stent, stent graft, heart valve and method of controlling same
US9827093B2 (en) 2011-10-21 2017-11-28 Edwards Lifesciences Cardiaq Llc Actively controllable stent, stent graft, heart valve and method of controlling same
CN107530162A (en) * 2015-05-11 2018-01-02 曲瓦斯库勒股份有限公司 Flexible stent graft with raising
US11376112B2 (en) 2017-01-31 2022-07-05 W. L. Gore & Associates, Inc. Pre-strained stent elements
US11786356B2 (en) 2010-12-22 2023-10-17 W. L. Gore & Associates, Inc. Biased endoluminal device

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6395019B2 (en) 1998-02-09 2002-05-28 Trivascular, Inc. Endovascular graft
US7128073B1 (en) 1998-11-06 2006-10-31 Ev3 Endovascular, Inc. Method and device for left atrial appendage occlusion
US7044134B2 (en) 1999-11-08 2006-05-16 Ev3 Sunnyvale, Inc Method of implanting a device in the left atrial appendage
US6187054B1 (en) * 1999-02-04 2001-02-13 Endomed Inc. Method of making large diameter vascular prosteheses and a vascular prosthesis made by said method
JP2004506479A (en) 2000-08-23 2004-03-04 エンドームド・インコーポレーテッド Manufacturing method of custom vascular interior device
US6716239B2 (en) 2001-07-03 2004-04-06 Scimed Life Systems, Inc. ePTFE graft with axial elongation properties
US7125464B2 (en) 2001-12-20 2006-10-24 Boston Scientific Santa Rosa Corp. Method for manufacturing an endovascular graft section
US6776604B1 (en) * 2001-12-20 2004-08-17 Trivascular, Inc. Method and apparatus for shape forming endovascular graft material
US7090693B1 (en) * 2001-12-20 2006-08-15 Boston Scientific Santa Rosa Corp. Endovascular graft joint and method for manufacture
US20040093068A1 (en) * 2002-07-24 2004-05-13 Bergen Lee C. Abdominal stent graft and delivery system
AU2003258240A1 (en) 2002-08-15 2004-03-03 Gmp Cardiac Care, Inc Stent-graft with rails
US20040093064A1 (en) * 2002-11-12 2004-05-13 Gjalt Bosma Drug eluting stent graft combination
US7025791B2 (en) 2002-12-02 2006-04-11 Gi Dynamics, Inc. Bariatric sleeve
US7608114B2 (en) 2002-12-02 2009-10-27 Gi Dynamics, Inc. Bariatric sleeve
EP1569582B1 (en) 2002-12-02 2017-05-31 GI Dynamics, Inc. Bariatric sleeve
US7678068B2 (en) 2002-12-02 2010-03-16 Gi Dynamics, Inc. Atraumatic delivery devices
US7766973B2 (en) 2005-01-19 2010-08-03 Gi Dynamics, Inc. Eversion resistant sleeves
US7695446B2 (en) 2002-12-02 2010-04-13 Gi Dynamics, Inc. Methods of treatment using a bariatric sleeve
WO2004082532A1 (en) * 2003-03-17 2004-09-30 Ev3 Sunnyvale, Inc. Thin film composite lamination
EP1610720B1 (en) * 2003-03-28 2009-02-18 GI Dynamics, Inc. Anti-obesity devices
US7735493B2 (en) 2003-08-15 2010-06-15 Atritech, Inc. System and method for delivering a left atrial appendage containment device
EP1708655A1 (en) 2003-12-09 2006-10-11 GI Dynamics, Inc. Apparatus to be anchored within the gastrointestinal tract and anchoring method
US8057420B2 (en) 2003-12-09 2011-11-15 Gi Dynamics, Inc. Gastrointestinal implant with drawstring
US7418464B2 (en) * 2004-01-27 2008-08-26 International Business Machines Corporation Method, system, and program for storing data for retrieval and transfer
US7766814B2 (en) * 2004-03-02 2010-08-03 Peter William Walsh Vessel or sac wall treatment and a cardiac assist device
US7195644B2 (en) * 2004-03-02 2007-03-27 Joint Synergy, Llc Ball and dual socket joint
JP4964134B2 (en) 2004-08-31 2012-06-27 シー・アール・バード・インコーポレーテッド Self-sealing PTFE graft with torsion resistance
US7524445B2 (en) * 2004-12-31 2009-04-28 Boston Scientific Scimed, Inc. Method for making ePTFE and structure containing such ePTFE, such as a vascular graft
US20060149366A1 (en) * 2004-12-31 2006-07-06 Jamie Henderson Sintered structures for vascular graft
US7806922B2 (en) * 2004-12-31 2010-10-05 Boston Scientific Scimed, Inc. Sintered ring supported vascular graft
US7857843B2 (en) 2004-12-31 2010-12-28 Boston Scientific Scimed, Inc. Differentially expanded vascular graft
US7771382B2 (en) 2005-01-19 2010-08-10 Gi Dynamics, Inc. Resistive anti-obesity devices
US7972359B2 (en) 2005-09-16 2011-07-05 Atritech, Inc. Intracardiac cage and method of delivering same
CA2626598A1 (en) 2005-11-09 2007-05-18 C.R. Bard Inc. Grafts and stent grafts having a radiopaque marker
US7819836B2 (en) 2006-06-23 2010-10-26 Gi Dynamics, Inc. Resistive anti-obesity devices
US8070895B2 (en) 2007-02-12 2011-12-06 United States Gypsum Company Water resistant cementitious article and method for preparing same
US8801647B2 (en) 2007-02-22 2014-08-12 Gi Dynamics, Inc. Use of a gastrointestinal sleeve to treat bariatric surgery fistulas and leaks
US8226701B2 (en) 2007-09-26 2012-07-24 Trivascular, Inc. Stent and delivery system for deployment thereof
US8066755B2 (en) 2007-09-26 2011-11-29 Trivascular, Inc. System and method of pivoted stent deployment
US8663309B2 (en) 2007-09-26 2014-03-04 Trivascular, Inc. Asymmetric stent apparatus and method
CN101917929A (en) 2007-10-04 2010-12-15 特里瓦斯库拉尔公司 Modular vascular graft for low profile percutaneous delivery
US8328861B2 (en) 2007-11-16 2012-12-11 Trivascular, Inc. Delivery system and method for bifurcated graft
US8083789B2 (en) 2007-11-16 2011-12-27 Trivascular, Inc. Securement assembly and method for expandable endovascular device
US8262979B2 (en) 2009-08-07 2012-09-11 Zeus Industrial Products, Inc. Process of making a prosthetic device from electrospun fibers
US20130268062A1 (en) 2012-04-05 2013-10-10 Zeus Industrial Products, Inc. Composite prosthetic devices
US8329308B2 (en) 2009-03-31 2012-12-11 United States Gypsum Company Cementitious article and method for preparing the same
US8992595B2 (en) 2012-04-04 2015-03-31 Trivascular, Inc. Durable stent graft with tapered struts and stable delivery methods and devices
US9498363B2 (en) 2012-04-06 2016-11-22 Trivascular, Inc. Delivery catheter for endovascular device
US10336036B2 (en) 2013-03-15 2019-07-02 United States Gypsum Company Cementitious article comprising hydrophobic finish
CN106137459B (en) * 2015-08-20 2018-02-23 上海市浦东医院 The method of the interim film covering device of intravascular stent and the interim overlay film of intravascular stent
US11432809B2 (en) 2017-04-27 2022-09-06 Boston Scientific Scimed, Inc. Occlusive medical device with fabric retention barb
EP3840670B1 (en) 2018-08-21 2023-11-15 Boston Scientific Scimed, Inc. Projecting member with barb for cardiovascular devices
EP3941392A1 (en) 2019-03-20 2022-01-26 Inqb8 Medical Technologies, LLC Aortic dissection implant
EP3998962A1 (en) 2019-07-17 2022-05-25 Boston Scientific Scimed, Inc. Left atrial appendage implant with continuous covering
US11540838B2 (en) 2019-08-30 2023-01-03 Boston Scientific Scimed, Inc. Left atrial appendage implant with sealing disk
EP4125634A1 (en) 2020-03-24 2023-02-08 Boston Scientific Scimed Inc. Medical system for treating a left atrial appendage

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3657744A (en) 1970-05-08 1972-04-25 Univ Minnesota Method for fixing prosthetic implants in a living body
US4140126A (en) 1977-02-18 1979-02-20 Choudhury M Hasan Method for performing aneurysm repair
US5122154A (en) 1990-08-15 1992-06-16 Rhodes Valentine J Endovascular bypass graft
US5123917A (en) 1990-04-27 1992-06-23 Lee Peter Y Expandable intraluminal vascular graft
US5507771A (en) 1992-06-15 1996-04-16 Cook Incorporated Stent assembly
US5700285A (en) 1993-08-18 1997-12-23 W. L. Gore & Associates, Inc. Intraluminal stent graft
US5749880A (en) 1995-03-10 1998-05-12 Impra, Inc. Endoluminal encapsulated stent and methods of manufacture and endoluminal delivery
US5824037A (en) 1995-10-03 1998-10-20 Medtronic, Inc. Modular intraluminal prostheses construction and methods
WO1999032051A1 (en) * 1997-12-22 1999-07-01 Impra, Inc. Supported graft and methods of making same

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE392582B (en) 1970-05-21 1977-04-04 Gore & Ass PROCEDURE FOR THE PREPARATION OF A POROST MATERIAL, BY EXPANDING AND STRETCHING A TETRAFLUORETENE POLYMER PREPARED IN AN PASTE-FORMING EXTENSION PROCEDURE
SE445884B (en) 1982-04-30 1986-07-28 Medinvent Sa DEVICE FOR IMPLANTATION OF A RODFORM PROTECTION
US4482516A (en) 1982-09-10 1984-11-13 W. L. Gore & Associates, Inc. Process for producing a high strength porous polytetrafluoroethylene product having a coarse microstructure
US4617932A (en) 1984-04-25 1986-10-21 Elliot Kornberg Device and method for performing an intraluminal abdominal aortic aneurysm repair
US4544711A (en) 1984-06-15 1985-10-01 Atlantic Richfield Company Process for making terminally functional polymers
US4580568A (en) 1984-10-01 1986-04-08 Cook, Incorporated Percutaneous endovascular stent and method for insertion thereof
US4800882A (en) 1987-03-13 1989-01-31 Cook Incorporated Endovascular stent and delivery system
US4907336A (en) 1987-03-13 1990-03-13 Cook Incorporated Method of making an endovascular stent and delivery system
DE3887084D1 (en) 1987-11-06 1994-02-24 Hoffmann La Roche Halogenated benzene derivatives.
US5019085A (en) 1988-10-25 1991-05-28 Cordis Corporation Apparatus and method for placement of a stent within a subject vessel
US5152782A (en) 1989-05-26 1992-10-06 Impra, Inc. Non-porous coated ptfe graft
US4955899A (en) 1989-05-26 1990-09-11 Impra, Inc. Longitudinally compliant vascular graft
CA2202800A1 (en) 1991-04-11 1992-10-12 Alec A. Piplani Endovascular graft having bifurcation and apparatus and method for deploying the same
US5197978B1 (en) 1991-04-26 1996-05-28 Advanced Coronary Tech Removable heat-recoverable tissue supporting device
US5662713A (en) 1991-10-09 1997-09-02 Boston Scientific Corporation Medical stents for body lumens exhibiting peristaltic motion
US5316023A (en) 1992-01-08 1994-05-31 Expandable Grafts Partnership Method for bilateral intra-aortic bypass
US5507767A (en) 1992-01-15 1996-04-16 Cook Incorporated Spiral stent
EP0596145B1 (en) 1992-10-31 1996-05-08 Schneider (Europe) Ag Disposition for implanting a self-expanding endoprothesis
US6027779A (en) 1993-08-18 2000-02-22 W. L. Gore & Associates, Inc. Thin-wall polytetrafluoroethylene tube
US5639278A (en) 1993-10-21 1997-06-17 Corvita Corporation Expandable supportive bifurcated endoluminal grafts
US5609627A (en) 1994-02-09 1997-03-11 Boston Scientific Technology, Inc. Method for delivering a bifurcated endoluminal prosthesis
US5507769A (en) 1994-10-18 1996-04-16 Stentco, Inc. Method and apparatus for forming an endoluminal bifurcated graft
US5415664A (en) 1994-03-30 1995-05-16 Corvita Corporation Method and apparatus for introducing a stent or a stent-graft
EP1582181A3 (en) * 1994-06-27 2010-04-21 Bard Peripheral Vascular, Inc. Radially expandable polytetrafluoroethylene and expandable endovascular stents formed therewith
US5575816A (en) 1994-08-12 1996-11-19 Meadox Medicals, Inc. High strength and high density intraluminal wire stent
US6015429A (en) 1994-09-08 2000-01-18 Gore Enterprise Holdings, Inc. Procedures for introducing stents and stent-grafts
CA2175720C (en) 1996-05-03 2011-11-29 Ian M. Penn Bifurcated stent and method for the manufacture and delivery of same
NL9500094A (en) 1995-01-19 1996-09-02 Industrial Res Bv Y-shaped stent and method of deployment.
US6039755A (en) * 1997-02-05 2000-03-21 Impra, Inc., A Division Of C.R. Bard, Inc. Radially expandable tubular polytetrafluoroethylene grafts and method of making same
EP0773754B1 (en) 1995-05-25 2004-09-01 Medtronic, Inc. Stent assembly
US5700269A (en) 1995-06-06 1997-12-23 Corvita Corporation Endoluminal prosthesis deployment device for use with prostheses of variable length and having retraction ability
US6042605A (en) 1995-12-14 2000-03-28 Gore Enterprose Holdings, Inc. Kink resistant stent-graft
US5800512A (en) 1996-01-22 1998-09-01 Meadox Medicals, Inc. PTFE vascular graft
UA58485C2 (en) 1996-05-03 2003-08-15 Медінол Лтд. Method for manufacture of bifurcated stent (variants) and bifurcated stent (variants)
US5928279A (en) 1996-07-03 1999-07-27 Baxter International Inc. Stented, radially expandable, tubular PTFE grafts
EP2298241A3 (en) 1996-12-03 2011-11-02 Atrium Medical Corporation Multi-stage prothesis
US5776142A (en) 1996-12-19 1998-07-07 Medtronic, Inc. Controllable stent delivery system and method
US6352561B1 (en) 1996-12-23 2002-03-05 W. L. Gore & Associates Implant deployment apparatus
US5961545A (en) 1997-01-17 1999-10-05 Meadox Medicals, Inc. EPTFE graft-stent composite device
US5843166A (en) 1997-01-17 1998-12-01 Meadox Medicals, Inc. Composite graft-stent having pockets for accomodating movement
US6090128A (en) 1997-02-20 2000-07-18 Endologix, Inc. Bifurcated vascular graft deployment device
EP1011529B1 (en) 1997-03-05 2005-01-26 Boston Scientific Limited Conformal laminate stent device
US5906641A (en) 1997-05-27 1999-05-25 Schneider (Usa) Inc Bifurcated stent graft

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3657744A (en) 1970-05-08 1972-04-25 Univ Minnesota Method for fixing prosthetic implants in a living body
US4140126A (en) 1977-02-18 1979-02-20 Choudhury M Hasan Method for performing aneurysm repair
US5123917A (en) 1990-04-27 1992-06-23 Lee Peter Y Expandable intraluminal vascular graft
US5122154A (en) 1990-08-15 1992-06-16 Rhodes Valentine J Endovascular bypass graft
US5507771A (en) 1992-06-15 1996-04-16 Cook Incorporated Stent assembly
US5700285A (en) 1993-08-18 1997-12-23 W. L. Gore & Associates, Inc. Intraluminal stent graft
US5749880A (en) 1995-03-10 1998-05-12 Impra, Inc. Endoluminal encapsulated stent and methods of manufacture and endoluminal delivery
US5824037A (en) 1995-10-03 1998-10-20 Medtronic, Inc. Modular intraluminal prostheses construction and methods
WO1999032051A1 (en) * 1997-12-22 1999-07-01 Impra, Inc. Supported graft and methods of making same

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7226558B2 (en) 2000-11-22 2007-06-05 Bard Peripheral Vascular, Inc. Method of making an expanded polytetrafluoroethylene structure
JP2009291626A (en) * 2001-12-20 2009-12-17 Trivascular2 Inc Method and apparatus for manufacturing endovascular graft section
EP1719538A4 (en) * 2004-02-27 2008-10-29 Sumitomo Electric Industries Composite structure and process for producing the same
AU2004316360B2 (en) * 2004-02-27 2010-06-17 Sumitomo Electric Industries, Ltd. Composite structure and process for producing the same
US8506750B2 (en) 2004-02-27 2013-08-13 Sumitomo Electric Industries, Ltd. Composite structure and process for producing the same
EP1719538A1 (en) * 2004-02-27 2006-11-08 Sumitomo Electric Industries, Ltd. Composite structure and process for producing the same
US8252036B2 (en) 2006-07-31 2012-08-28 Syntheon Cardiology, Llc Sealable endovascular implants and methods for their use
US9138335B2 (en) 2006-07-31 2015-09-22 Syntheon Cardiology, Llc Surgical implant devices and methods for their manufacture and use
US9827125B2 (en) 2006-07-31 2017-11-28 Edwards Lifesciences Cardiaq Llc Sealable endovascular implants and methods for their use
US9585743B2 (en) 2006-07-31 2017-03-07 Edwards Lifesciences Cardiaq Llc Surgical implant devices and methods for their manufacture and use
US9814611B2 (en) 2007-07-31 2017-11-14 Edwards Lifesciences Cardiaq Llc Actively controllable stent, stent graft, heart valve and method of controlling same
US9408607B2 (en) 2009-07-02 2016-08-09 Edwards Lifesciences Cardiaq Llc Surgical implant devices and methods for their manufacture and use
US9566178B2 (en) 2010-06-24 2017-02-14 Edwards Lifesciences Cardiaq Llc Actively controllable stent, stent graft, heart valve and method of controlling same
US11786356B2 (en) 2010-12-22 2023-10-17 W. L. Gore & Associates, Inc. Biased endoluminal device
US9827093B2 (en) 2011-10-21 2017-11-28 Edwards Lifesciences Cardiaq Llc Actively controllable stent, stent graft, heart valve and method of controlling same
CN107530162A (en) * 2015-05-11 2018-01-02 曲瓦斯库勒股份有限公司 Flexible stent graft with raising
EP3294210A4 (en) * 2015-05-11 2019-01-02 TriVascular, Inc. Stent-graft with improved flexibility
CN107530162B (en) * 2015-05-11 2020-01-24 曲瓦斯库勒股份有限公司 Stent graft with improved flexibility
US11376112B2 (en) 2017-01-31 2022-07-05 W. L. Gore & Associates, Inc. Pre-strained stent elements

Also Published As

Publication number Publication date
CA2378360A1 (en) 2001-02-01
ES2235925T3 (en) 2005-07-16
EP1579825A2 (en) 2005-09-28
JP2003505144A (en) 2003-02-12
ATE286690T1 (en) 2005-01-15
PT1202682E (en) 2005-05-31
AU6492200A (en) 2001-02-13
EP1202682A1 (en) 2002-05-08
DE60017411D1 (en) 2005-02-17
DE60017411T2 (en) 2005-06-02
EP1202682B1 (en) 2005-01-12
EP1579825A3 (en) 2007-12-26
US6402779B1 (en) 2002-06-11

Similar Documents

Publication Publication Date Title
EP1202682B1 (en) Intraluminal stent graft
US8647458B2 (en) Methods for making a supported graft
US6336937B1 (en) Multi-stage expandable stent-graft
EP0850030B1 (en) Method of assembly of a covered endoluminal stent
EP1207815B1 (en) Tubular stent-graft composite device and method of manufacture
US5700285A (en) Intraluminal stent graft
US5993489A (en) Tubular intraluminal graft and stent combination
CA2152662C (en) Bistable luminal graft endoprostheses
JP2006512099A (en) Composite vascular graft
EP1345555B1 (en) Composite tubular prostheses
EP1767169B1 (en) Tubular stent-graft composite device and method of manufacture

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2378360

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2000952172

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2000952172

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWG Wipo information: grant in national office

Ref document number: 2000952172

Country of ref document: EP